Healthcare - Biotechnology - NASDAQ - US
$ 4.53
-3.41 %
$ 36.1 M
Market Cap
-1.52
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
327.43%
EBIT
Estimate
--34.07%
Net Income
Estimate
85.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Clene Inc.
CLNN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CLNN
EBIT FORECAST
EBIT Forecast Chart CLNN
NET INCOME FORECAST
Net Income Chart CLNN